Markets

Markets Overview Market Context

Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Market Context Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Live News REGULATION FLASH L impact Oct 14, 2026, 10:24 AM UTC

Supreme Court Dismisses Cosette Appeal, Mayne Pharma Says

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

MYX

Related stories

US Bank Regulator Faults Large Lenders Over Debanking Practices A report found that several of the country’s largest banks unfairly denied banking services to some clients on political, religious or other grounds. The regulator stopped short of M impact | REGULATION | Oct 14, 2026, 11:15 AM UTC Xeris Biopharma files New Jersey patent suits after KEVEYIS patent grant Xeris Biopharma filed patent infringement suits on Oct. 13, 2026 in New Jersey federal court tied to KEVEYIS (dichlorphenamide). Actions follow issuance of U.S. Patent No. 12,758,5 L impact | REGULATION | Oct 14, 2026, 11:10 AM UTC United Therapeutics, Liquidia settle Yutrepia patent litigation, agree to dismiss cases with prejudice United Therapeutics reached a settlement with Liquidia to end multiple patent disputes tied to Yutrepia sales and labeling. Liquidia must pay USD 185 million within 30 business day L impact | REGULATION | Oct 14, 2026, 11:06 AM UTC Pelage Pharmaceuticals Announces First Patient Dosed in Phase 2/3 AWAKEN Trial of PP405 for Androgenetic Alopecia, the Most Common Form of Hair Loss For best results when printing this announcement, please click on link below: Pelage Pharmaceuticals Announces First Patient Dosed in Phase 2/3 AWAKEN Trial of PP405 for Androgenet H impact | REGULATION | Oct 14, 2026, 11:01 AM UTC VSE Corporation Announces Investor Day Event in New York City For best results when printing this announcement, please click on link below: VSE Corporation Announces Investor Day Event in New York City Event to feature executive presentations H impact | REGULATION | Oct 14, 2026, 11:01 AM UTC eGenesis to Participate in the Virtual U.S. Bancorp | BTIG Kidney Health Forum with Panel Discussion and Investor Meetings For best results when printing this announcement, please click on link below: eGenesis to Participate in the Virtual U.S. Bancorp | BTIG Kidney Health Forum with Panel Discussion a H impact | REGULATION | Oct 14, 2026, 11:01 AM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.